TrialBMC cancer2016

Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma.

Yan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.